Part Details | USP BACITRACIN ZINC AND POLYMYXIN B SULFATE OINTMENT
6505-01-493-3826
Alternate Parts: NDC00168002109, NDC00168-0021-09, NDC00168002109, NDC00168-0021-09, 010681, 01-0681, 6505NCM010498, NDC00168002109, NDC00168-0021-09, 6505-01-493-3826, 01-493-3826, 6505014933826, 014933826
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | JAN 03, 2002 | 01-493-3826 | 36449 ( BACITRACIN ZINC AND POLYMYXIN B SULFATE OINTMENT, USP ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-493-3826
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| NDC00168-0021-09 | 1XUY5 | AMERISOURCEBERGEN DRUG CORPORATIONDIV CORPORATE OFFICE |
| NDC00168-0021-09 | 00E55 | CARDINAL HEALTH, INC.DBA CARDINAL HEALTH |
| 01-0681 | 89875 | DEFENSE LOGISTICS AGENCYDIRECTORATE OF MEDICAL MATERIEL |
| 6505NCM010498 | 64616 | DEFENSE MEDICAL STANDARDIZATIONBOARD |
| NDC00168-0021-09 | 60910 | FOUGERA PHARMACEUTICALS INC.DBA PHARMADERM |
Technical Data | NSN 6505-01-493-3826
| Characteristic | Specifications |
|---|---|
| ACTIVE INGREDIENT AND STRENGTH | 500.000 BACITRACIN ZINC UNITS AND 10000.000 POLYMYXIN B SULFATE UNITS |
| ADMINISTRATION | TOPICAL |
| PRIMARY CONTAINER TYPE | DY ANY ACCEPTABLE |
| PRIMARY CONTAINER CONTENT QUANTITY | 0.031 OUNCES |
| TOTAL PRIMARY CONTAINER QUANTITY | 144 |
| FEATURES PROVIDED | INDIVIDUALLY FOIL WRAPPED |
| SPECIAL FEATURES | DOUBLE ANTIBIOTIC OINTMENT; 1/32 OZ. IN FOILPAC WITH 144 PACS IN A PACKAGE |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | BACITRACIN ZINC POLYMIXIN B SULFATE OINTMENT USP 1/32OZ PACK 144S |